Asia Pacific Bone Growth Stimulators Market was worth USD 0.27 billion in 2019 and estimated to be growing at a CAGR of 5.5%, to reach USD 0.350 Billion by 2024 during the forecast period 2019-2024.
Bone growth stimulators are used for speeding up the fracture healing process when there is delay or inability to do so by the body on its own. They increase the natural speed of the bone-healing process without giving electric shocks when worn by the user. External bone growth stimulator are also called non-invasive bone growth stimulators and are mobile devices worn externally. They do not need surgery for implantation. An external bone growth stimulator is advised to be kept for two to nine hours per day for around three to nine months in a year. An internal bone growth stimulator is an invasive bone growth stimulator and is implanted on the fusion spot of the bone. It gives off small electrical currents. The internal bone growth stimulator is removed from the fusion spot after a year. The market is estimated to grow at a significant potential during the specified period and also in the years to follow.
Asia-Pacific Bone-growth stimulators market is driven by factors like increasing elderly population, rising prevalence of arthritis and injuries caused by sports and growing demand for non-invasive spinal surgeries. On the other hand, factors like the feasibility of other treatment options, doubtful efficiency of the procedure, problems due to issues in the medical device, lack of awareness and government support along with competition from bone grafting act as constraints for the growth of bone growth stimulators market.
This research report on the Asia Pacific Bone Growth Stimulators Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024.
By Product: Bone Growth Stimulation Devices (External Bone Growth Stimulators, Implanted Bone Growth Stimulators and Ultrasonic Bone Growth Stimulators) , Bone Morphogenetic Proteins and Platelet-rich Plasma..
By Application: Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral and Maxillofacial Surgeries.
By End User: Hospitals and Clinics, Home Care, Academic & Research Institutes and CROs.
By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC
Major Companies in the Market:
Major Companies dominating the Asia Pacific Bone Growth Stimulators Market are DJO LLC, Orthofix International N.V., Zimmer Biomet Holdings Inc., Elizur, Bioventus LLC., Ossatec Benelux BV, Verve Consulting Inc., and IGEA S.p.A.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Bone Growth Stimulation Devices
5.1.2.1 External Bone Growth Stimulators
5.1.2.2 Implanted Bone Growth Stimulators
5.1.2.3 Ultrasonic Bone Growth Stimulators
5.1.3 Bone Morphogenetic Proteins
5.1.4 Platelet-rich Plasma
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Spinal Fusion Surgeries
5.2.3 Delayed Union & Nonunion Bone Fractures
5.2.4 Other Applications
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
5.3 End user
5.3.1 Introduction
5.3.2 Hospitals and Clinics
5.3.3 Home Care
5.3.4 Academic & Research Institutes
5.3.5 CROs
5.3.6 Y-o-Y Growth Analysis, By End user
5.3.7 Market Attractiveness Analysis, By End user
5.3.8 Market Share Analysis, By End user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.3.4 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.4.4 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.1.5.4 By End user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 DJO LLC
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Orthofix International N.V
8.3 Zimmer Biomet Holdings Inc
8.4 Elizur, Bioventus LLC
8.5 Ossatec Benelux BV
8.6 Verve Consulting Inc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
